Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:
• Documented diagnosis of diabetes mellitus by definition.
• Understanding of the Study and willingness and ability to sign informed consent
• Patient age 18 or above
• Diagnostic for diabetes: 4a) Type 1 diabetes of a lest 5 years of evolution; or 4b) Type 2 diabetes
Locations
Other Locations
Ukraine
The Filatov Institute of Eye Diseases and Tissue Therapy
RECRUITING
Odesa
Contact Information
Primary
Andrii MD Korol, PhD
andrii.r.korol@gmail.com
380936327266
Backup
Olha MD Pohosian
olha.a.pohosian@gmail.com
380932084927
Time Frame
Start Date: 2024-11-02
Estimated Completion Date: 2025-12
Participants
Target number of participants: 200
Treatments
main group
have diabetes mellitus
control group
have risk factors for developing diabetes mellitus
Related Therapeutic Areas
Sponsors
Leads: The Filatov Institute of Eye Diseases and Tissue Therapy
Collaborators: CheckEye LLC, Oftacentro SA